We are live on
!
Find out more
MLL
Moody Lynn & Lieberson Portfolio holdings
AUM
$1.9B
1-Year Est. Return
27.82%
This Fund
S&P 500
This Quarter
Est. Return
+15.94%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$873M
AUM Growth
+$129M
(+17%)
Cap. Flow
+$29.7M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
30.52%
Holding
204
New
16
Increased
60
Reduced
73
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$10.7M |
| 2 |
Salesforce
CRM
|
+$10.6M |
| 3 |
Paycom
PAYC
|
+$8.67M |
| 4 |
HealthEquity
HQY
|
+$7.6M |
| 5 |
Alibaba
BABA
|
+$7.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$8.66M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$7M |
| 3 |
Boston Scientific
BSX
|
+$5.64M |
| 4 |
Apple
AAPL
|
+$5.54M |
| 5 |
Merck
MRK
|
+$5.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Financials | 18.7% |
| 3 | Healthcare | 14.12% |
| 4 | Industrials | 10.57% |
| 5 | Consumer Staples | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Netflix
NFLX
$309B
| $802K | 0.09% |
22,480
+3,330
| +17% | +$115K |
|
102
Dover
DOV
$28.4B
| $780K | 0.09% |
8,316
-178
| -2% | -$15.4K |
|
103
MSCI
MSCI
$40.9B
| $766K | 0.09% |
3,850
-99
| -3% | -$17.2K |
|
104
HubSpot
HUBS
$10.5B
| $761K | 0.09% |
4,576
-107
| -2% | -$16.9K |
|
105
Amphenol
APH
$209B
| $756K | 0.09% |
32,000
| – | – |
|
106
Mettler-Toledo International
MTD
$28.6B
| $748K | 0.09% |
1,034
-51
| -5% | -$33.2K |
|
107
Vanguard Dividend Appreciation ETF
VIG
$114B
| $744K | 0.09% |
6,785
-53
| -0.8% | -$5.59K |
|
|
108
Boston Scientific
BSX
$71.5B
| $719K | 0.08% |
18,730
-147,700
| -89% | -$5.64M |
|
109
Danaher
DHR
$144B
| $713K | 0.08% |
6,089
-47,224
| -89% | -$4.84M |
|
110
Revvity
RVTY
$12.8B
| $712K | 0.08% |
7,392
-175
| -2% | -$15.8K |
|
111
Emerson Electric
EMR
$88.3B
| $709K | 0.08% |
10,350
| – | – |
|
112
Edwards Lifesciences
EW
$51.7B
| $708K | 0.08% |
+11,100
| New | +$633K |
|
113
Blackrock
BLK
$176B
| $685K | 0.08% |
1,602
-2,035
| -56% | -$854K |
|
114
Republic Services
RSG
$66B
| $671K | 0.08% |
8,342
-258
| -3% | -$19.9K |
|
|
TXNM
115
TXNM Energy Inc
TXNM
$5.94B
| $670K | 0.08% |
14,150
-492
| -3% | -$21.5K |
|
116
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $653K | 0.07% |
1,890
+95
| +5% | +$32K |
|
117
L3Harris
LHX
$53.4B
| $643K | 0.07% |
4,024
-1,510
| -27% | -$233K |
|
|
FRC
118
DELISTED
First Republic Bank
FRC
| $641K | 0.07% |
6,382
-221
| -3% | -$21.8K |
|
119
SS&C Technologies
SSNC
$18.6B
| $634K | 0.07% |
9,953
-352
| -3% | -$19.6K |
|
120
Royal Caribbean
RCL
$85.6B
| $630K | 0.07% |
5,495
-149
| -3% | -$16.9K |
|
121
Cabot Corp
CBT
$4.52B
| $624K | 0.07% |
15,000
| – | – |
|
|
XYZ
122
Block Inc
XYZ
$47.5B
| $616K | 0.07% |
+8,220
| New | +$596K |
|
|
SPLK
123
DELISTED
Splunk Inc
SPLK
| $606K | 0.07% |
4,865
-161
| -3% | -$20.1K |
|
124
Starbucks
SBUX
$120B
| $603K | 0.07% |
8,108
-223
| -3% | -$15.3K |
|
125
NextEra Energy
NEE
$177B
| $602K | 0.07% |
12,452
| – | – |
|
Similar funds
EP
DCP
FTCM
IAN
VC
TF
SGF
BOH
Moody Lynn & Lieberson's Q1 2019 Portfolio in Review
As of Q1 2019, Moody Lynn & Lieberson held 204 positions worth $873M, up 17% from $744M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Moody Lynn & Lieberson deployed $29.7M of net new capital in Q1 2019, opening 16 new positions and adding to 60 existing holdings. Its largest new stake was HealthEquity: 108,043 shares worth $7.99M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $7M trimmed.
- Moody Lynn & Lieberson's largest Q1 2019 buy was HealthEquity: 108,043 shares worth $7.99M.
- Moody Lynn & Lieberson added most to Vanguard FTSE Emerging Markets ETF in Q1 2019, an estimated $10.7M increase.
- Moody Lynn & Lieberson's biggest Q1 2019 reduction was Berkshire Hathaway Class B, cutting an estimated $7M.
- Moody Lynn & Lieberson fully exited Amgen in Q1 2019, selling an estimated $8.66M.
- Moody Lynn & Lieberson's ten largest holdings make up 31% of its $873M portfolio in Q1 2019.
- Moody Lynn & Lieberson opened 16 new positions and closed 19 in Q1 2019.
- Moody Lynn & Lieberson's portfolio value rose 17% quarter-over-quarter to $873M.
Based on Moody Lynn & Lieberson's 13F filing for Q1 2019, filed 23 Apr 2019.